Lexicon Pharmaceuticals (LXRX) Short Interest Ratio & Short Volume → The most important AI company you've never heard of (From Manward Press) (Ad) Free LXRX Stock Alerts $1.94 +0.02 (+1.04%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Lexicon Pharmaceuticals Short Interest DataCurrent Short Volume23,440,000 sharesPrevious Short Volume20,120,000 sharesChange Vs. Previous Month+16.50%Dollar Volume Sold Short$36.10 millionShort Interest Ratio / Days to Cover5.3Last Record DateApril 30, 2024Outstanding Shares246,240,000 sharesPercentage of Shares Shorted9.52%Today's Trading Volume1,465,795 sharesAverage Trading Volume4,148,509 sharesToday's Volume Vs. Average35% Short Selling Lexicon Pharmaceuticals ? Sign up to receive the latest short interest report for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLXRX Short Interest Over TimeLXRX Days to Cover Over TimeLXRX Percentage of Float Shorted Over Time Ad Chaikin AnalyticsThis Wall Street stock prediction just went viralPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch just the first 5 minutes of his new prediction Lexicon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202423,440,000 shares $36.10 million +16.5%N/A5.3 $1.54 4/15/202420,120,000 shares $37.62 million -8.2%N/A4.2 $1.87 3/31/202421,910,000 shares $52.58 million +2.6%N/A4.7 $2.40 3/15/202421,350,000 shares $55.51 million +1.3%N/A4.6 $2.60 2/29/202421,070,000 shares $52.46 million -10.0%N/A4.9 $2.49 2/15/202423,410,000 shares $83.81 million +1.7%N/A6.4 $3.58 Get the Latest News and Ratings for LXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202423,030,000 shares $43.07 million -8.9%N/A8 $1.87 1/15/202425,270,000 shares $34.62 million +8.8%N/A10.3 $1.37 12/31/202323,220,000 shares $35.53 million -0.3%N/A8.6 $1.53 12/15/202323,280,000 shares $29.57 million -0.5%N/A9.1 $1.27 11/30/202323,400,000 shares $24.80 million +4.6%N/A9.3 $1.06 11/15/202322,370,000 shares $25.50 million +1.8%N/A9.3 $1.14 10/31/202321,980,000 shares $27.26 million +12.7%N/A9.9 $1.24 10/15/202319,500,000 shares $23.21 million -3.7%N/A9.1 $1.19 9/30/202320,240,000 shares $22.06 million +7.1%N/A11.2 $1.09 9/15/202318,900,000 shares $26.46 million +6.1%N/A11.5 $1.40 8/31/202317,810,000 shares $30.63 million +1.5%N/A9.5 $1.72 8/15/202317,550,000 shares $28.61 million -2.2%N/A6.6 $1.63 7/31/202317,950,000 shares $36.08 million +14.2%N/A6.9 $2.01 7/15/202315,720,000 shares $34.74 million +8.7%N/A6.3 $2.21 6/30/202314,460,000 shares $33.11 million +38.0%N/A6.1 $2.29 6/15/202310,480,000 shares $26.93 million -2.6%N/A4.9 $2.57 5/31/202310,760,000 shares $35.51 million +66.8%N/A6.3 $3.30 5/15/20236,450,000 shares $19.22 million +30.8%N/A8.5 $2.98 4/30/20234,930,000 shares $11.78 million +17.4%N/A8.1 $2.39 4/15/20234,200,000 shares $10.12 million +3.5%N/A9.5 $2.41 3/31/20234,060,000 shares $9.87 million +2.3%N/A10.3 $2.43 3/15/20233,970,000 shares $9.09 million +4.2%N/A9.3 $2.29 2/28/20233,810,000 shares $8.57 million -8.0%N/A9.3 $2.25 2/15/20234,140,000 shares $9.44 million +3.5%N/A11.3 $2.28 1/31/20234,000,000 shares $8.96 million +2.6%N/A10.6 $2.24 1/15/20233,900,000 shares $9.20 million +0.3%N/A9.8 $2.36 12/30/20223,890,000 shares $7.43 million +2.9%N/A9.3 $1.91 12/15/20223,780,000 shares $8.05 million +0.3%N/A8.6 $2.13 11/30/20223,770,000 shares $8.07 million -2.3%N/A7.8 $2.14 11/15/20223,860,000 shares $8.96 million -9.4%N/A7.5 $2.32 10/31/20224,260,000 shares $9.16 million -4.7%N/A6.4 $2.15 10/15/20224,470,000 shares $9.43 million -0.2%N/A4.4 $2.11 9/30/20224,480,000 shares $10.75 million +11.4%N/A4.3 $2.40 9/15/20224,020,000 shares $10.77 million +7.8%N/A2.4 $2.68Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge LXRX Short Interest - Frequently Asked Questions What is Lexicon Pharmaceuticals' current short interest? Short interest is the volume of Lexicon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 23,440,000 shares of LXRX short. Learn More on Lexicon Pharmaceuticals' current short interest. What is a good short interest ratio for Lexicon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LXRX shares currently have a short interest ratio of 5.0. Learn More on Lexicon Pharmaceuticals's short interest ratio. Is Lexicon Pharmaceuticals' short interest increasing or decreasing? Lexicon Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 23,440,000 shares, an increase of 16.5% from the previous total of 20,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Lexicon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lexicon Pharmaceuticals: Verastem, Inc. (3.49%), Vanda Pharmaceuticals Inc. (4.17%), XOMA Co. (2.33%), Emergent BioSolutions Inc. (14.13%), Merrimack Pharmaceuticals, Inc. (5.80%), Rigel Pharmaceuticals, Inc. (3.23%), Regulus Therapeutics Inc. (7.33%), Rezolute, Inc. (0.78%), OPKO Health, Inc. (26.42%), Innoviva, Inc. (18.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lexicon Pharmaceuticals stock? Short selling LXRX is an investing strategy that aims to generate trading profit from Lexicon Pharmaceuticals as its price is falling. LXRX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexicon Pharmaceuticals? A short squeeze for Lexicon Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LXRX, which in turn drives the price of the stock up even further. How often is Lexicon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LXRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VSTM Short Interest Data VNDA Short Interest Data XOMA Short Interest Data EBS Short Interest Data MACK Short Interest Data RIGL Short Interest Data RGLS Short Interest Data RZLT Short Interest Data OPK Short Interest Data INVA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LXRX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeProtect Your Bank Account Before It’s Too LateWeiss Ratings